Efficacy of subcutaneous interferon-beta in COVID-19: a meta-analysis and systematic review

Efficacy of subcutaneous interferon-beta in COVID-19: a meta-analysis and systematic review

Type 1 interferons, especially interferon-beta, has been reported to be effective in COVID-19 patients in multiple randomized controlled trials. The aim of our meta-analysis and systematic review is to assess efficacy of subcutaneous IFN-beta in regards to mortality and discharge rate. Prospective,...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Abuzar A. Asif, Habiba Hussain, Sriviji Senthil Kumaran, Salman B. Syed, Varun Vanka, Manisha Tharoor, Umme Salma Rangwala, Urvashi Rathore, Malay Singhal, Tulika Chatterjee
Format: article
Langue:EN
Publié: Taylor & Francis Group 2021
Sujets:
interferon-beta
covid-19
coronavirus
meta-analysis
systematic review
pandemic
efficacy
subcutaneous
Internal medicine
RC31-1245
Accès en ligne:https://doaj.org/article/543ed69dc9d34b20a702f2a6015eb96c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/543ed69dc9d34b20a702f2a6015eb96c

Documents similaires